This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

ReFacto AF (moroctocog alfa) Prescribing Information for Great Britain click here. ReFacto AF (moroctocog alfa) Prescribing Information for Northern Ireland click here.
Adverse event reporting information can be found at the bottom of the page.


​​​​​​ReFacto AF® (moroctocog alfa) is indicated for the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). ReFacto AF® is appropriate for use in adults and children of all ages, including newborns. ReFacto AF® does not contain von Willebrand factor, and hence is not indicated in von Willebrand's disease.1

Pfizer support for healthcare professionals  

Pfizer Ltd. is committed to helping health care professionals support their patients.  ​​​​​​​

Pfizer ReFacto AF® supply and stock support  

Use SMART Hub which aims to support you in caring for your patients by enabling access to real-time stock information and where needed, providing key information on Pfizer medicines.  

Login or register for access here

If your local home branch of Alliance Healthcare has no stock available to fulfil your order, the Pfizer Ltd. Customer Contact Centre is available on 0345 608 8866 to check current stock availability.  

Explore More  

Pfizer support for patients  

Pfizer Ltd. is committed to helping patients manage their day-to-day lives.  

Find out more

Contact us

Contact a member of the Pfizer haemophilia team.

Contact us

** This is an optional area where footnotes can live.

ReFacto AF® Laboratory Standard  

Contact us to request information on how to use the ReFacto AF Laboratory Standard.

Contact us

** This is an optional area where footnotes can live.

Monitoring  

The use of the ReFacto AF® Laboratory Standard allows for consistent results regardless of assay type.  

Find out more  

** This is an optional area where footnotes can live.


References
  1. ReFacto AF® Summary of Product Characteristics. For Great Britain, available here. For Northern Ireland, available here.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
​​​​​​​Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-REF-GBR-0272. September 2021.

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

Yes

No